Pulmonary Disease

Pulmonary Disease

Patients will be considered to be in the terminal stage of pulmonary disease if they meet the following criteria. The criteria refer to patients with various forms of advanced pulmonary disease who eventually follow a final common pathway for end-stage pulmonary disease. 1 and 2should be present; documentation of 3, 4 or 5 will lend supporting documentation:

• Severe chronic lung disease as documented by both criteria below:
• • Disabling dyspnea at rest, poorly or unresponsive to bronchodilators, resulting in decreased functional capacity, e.g., bed-to-chair existence, fatigue and cough (documentation of forced expiratory volume in one second (FEV1), after bronchodilator, less than 30% of predicted is objective evidence for disabling dyspnea, but is not necessary to obtain).
• • Progression of end-stage pulmonary disease; as evidenced by increasing visits to the emergency department, hospitalizations for pulmonary infections, respiratory failure or increasing physician home visits prior to initial certification. (Documentation of serial decrease of FEV1 > 40 ml/year is objective evidence for disease progression but is not necessary to obtain.)


• Hypoxemia at rest on room air, as evidenced by pO2 ≤ 55 mmHg; or oxygen saturation ≤88%, determined either by arterial blood gases or oxygen saturation monitors (these values may be obtained from recent hospital records) or Hypercapnia, as evidenced by pCO2 ≥50 mmHg (this value may be obtained from recent — within 3 months — hospital records).


• Documentation of the following factors will support eligibility for hospice care:
• • Right heart failure (RHF) secondary to pulmonary disease (Cor pulmonale) (e.g., not secondary to left heart disease or valvulopathy).
• • Unintentional progressive weight loss of greater than 10% of body weight over the preceding six months.
• • Resting tachycardia > 100/min.